Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Douglas C. Powers"'
Autor:
Sharon Irby-Moore, Kathleen R. Lottenbach, Donald J. Kennedy, Douglas C. Powers, Dan M. Granoff, Sharon M. Homan, Stephen J. Barenkamp, ChrisAnna M. Mink
Publikováno v:
Journal of the American Geriatrics Society. 52:1883-1887
Objectives: To evaluate the safety and immunogenicity of unconjugated Haemophilus influenzae type b (Hib) polysaccharide (PRP) vaccine and two PRP-protein-conjugated vaccines as a model for the comparison of protein-conjugated versus plain polysaccha
Autor:
Stephen J. Barenkamp, Douglas C. Powers, Kathleen R. Lottenbach, Edwin L. Anderson, Sharon M. Homan, ChrisAnna M. Mink
Publikováno v:
Infection and Immunity. 67:4935-4938
Immunoglobulin G (IgG) subclass antibody responses to pneumococcal vaccines were determined for human subjects in four age groups. The ratios of IgG1/IgG2 antibody concentrations declined with advancing age for all five of the serotypes tested. Prote
Autor:
Geoffrey J. Gorse, Esther E. Otto, Carlos C. Daughaday, Christopher S. Eickhoff, Frances K. Newman, Rodney H. Lusk, Douglas C. Powers
Publikováno v:
Chest. 112:1221-1233
Study objectives To evaluate the safety of, and mucosal and systemic immune responses induced by two influenza virus vaccine regimens in subjects with COPD. Design Single-center, blinded, randomized, prospective clinical trial evaluating two vaccine
Autor:
John J. Treanor, Bethanie E. Wilkinson, Robert B. Belshe, Gale Smith, Craig Stanway Hackett, Douglas C. Powers, Edwin L. Anderson, Robert F. Betts
Publikováno v:
Journal of Infectious Diseases. 173:1467-1470
Healthy subjects45 years old (young adults) or65 (elderly adults) were randomized in double-blind fashion to receive intramuscularly subvirion trivalent influenza vaccine, placebo, or 15, 45, or 135 microgram of the hemagglutinin (HA) of the influenz
Publikováno v:
Journal of the American Geriatrics Society. 44:699-703
OBJECTIVE: To compare in adults more than 50 years old the tolerability and immunogenicity of vaccination with recombinant hepatitis B surface antigen (HBs) compared with vaccination with recombinant hepatitis B protein PreS2+S, and to investigate th
Publikováno v:
Journal of Infectious Diseases. 173:1014-1018
Healthy adults > or = 50 years old were immunized with either pentavalent Corynebacterium diphtheriae C7 (beta197) cross-reactive material (CRM197) protein-conjugated pneumococcal vaccine (CV) containing 10 microgram each of capsular oligosaccharides
Autor:
Geoffrey J. Gorse, Esther E. Otto, Guy W. Chambers, Douglas C. Powers, Frances K. Newman, Christopher S. Eickhoff
Publikováno v:
Journal of Infectious Diseases. 173:285-290
Induction of local antibody responses to influenza A virus hemagglutinin by coadministration of two vaccines was investigated. Fifty elderly nursing home residents received inactivated trivalent influenza virus vaccine intramuscularly and simultaneou
Autor:
Guy W. Chambers, Douglas C. Powers, Mark J. Campbell, Frances K. Newman, Geoffrey J. Gorse, Esther E. Otto
Publikováno v:
Journal of Infectious Diseases. 172:1-10
The possible enhancement of anti-influenza A virus memory cytotoxic T cell (CTL) responses to inactivated influenza virus vaccine by coadministration of intranasal live attenuated influenza A virus vaccine was investigated. Fifty elderly nursing home
Publikováno v:
Vaccine. 13:1330-1335
In a randomized, double-blinded study, 77 healthy elderly seropositive volunteers (95% of whom had received influenza vaccine within the prior 5 years) were immunized with either monovalent liposome-adjuvanted or control subvirion vaccine containing
Autor:
Douglas C. Powers
Publikováno v:
Journal of Medical Virology. 43:57-61
We previously reported an age-associated impairment of serum immunoglobulin G (IgG) antibody responses to inactivated influenza virus vaccine. The present study extends these observations by examining the IgG subclass distribution of vaccine response